Acceptability and Use of PrEP Products Among Women Tool
This survey tool was developed in collaboration with the Women at Risk (WAR) Committee to be used across different HIV prevention clinical trials to assess women’s experiences with investigational products.
Acceptability and Use of PrEP Products Among Women Tool
Substance Use Measure Identification Tool
The Substance Use Scientific Committee (SUSC) at the HPTN has developed a Web-based, interactive Substance Use Measurement Identification (SUMI) tool to assist researchers to identify the proper biomarkers and behavioral survey tools to assess substance use in the setting of HIV. Based on the parameters entered by the user, the tool will list appropriate survey instruments relevant to particular substance use domains that the user plans to measure. This free, Web-based tool is available to researchers around the globe.
Substance Use Measure Identification Tool
Depression Measures Recommendations
The Mental Health Subgroup of the HPTN Socio-Behavioral and Structural Working Group (SBSWG) was formed to aid the larger working group in developing responses to network-wide issues around mental health. The SBSWG MHS has developed a document to provide recommendations for network-wide use of depression measures in HPTN studies, including the PHQ and the CES-D, which can be accessed below. The construct of depressive symptoms is important for both PLHIV and those who may acquire HIV and, thus, should be included in HIV prevention trials.
Depression Measures Recommendations
PTSD Measures Recommendations
As mentioned above, the Mental Health Subgroup of the HPTN Socio-Behavioral and Structural Working Group (SBSWG) was formed to aid the larger working group in developing responses to network-wide issues around mental health. The SBSWG MHS has developed a document to provide recommendations for network-wide use of PTSD measures in HPTN studies, including the PC-PTSD-5 and the PCL-5, which can be accessed below. As is the case with depressive symptoms, the construct of PTSD is important for both PLHIV and those who may acquire HIV and, thus, should be included in HIV prevention trials.